Lv1
40 积分 2025-06-12 加入
Microangiopathic Lesions in IgA Nephropathy: A Cohort Study
2个月前
已完结
Complement factor H variants are associated with microangiopathy lesions in IgA nephropathy
2个月前
已完结
Arteriolar C4d in IgA Nephropathy: A Cohort Study
2个月前
已完结
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
2个月前
已完结
The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
2个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
2个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy
2个月前
已完结
The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy
2个月前
已完结
Shenkangling alleviates renal fibrosis induced by renal ischemia–reperfusion injury by mitigating mitochondrial damage through modulation of the STING signaling pathway
3个月前
已完结
皖公网安备34019202002308
